Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes

Código QR

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes

Abstract Background Type 2 diabetes is a condition associated with a state of low-grade inflammation caused by adipose tissue dysfunction and insulin resistance. High sensitive-CRP (hs-CRP) is a marker for systemic low-grade inflammation and higher plasma levels have been associated with cardiovascu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shahnam Sharif, Y. Van der Graaf, M. J. Cramer, L. J. Kapelle, G. J. de Borst, Frank L. J. Visseren, Jan Westerink, the SMART study group
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/d111bce3c9f04bb99a2b41879fa13076
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ceramide Remodeling and Risk of Cardiovascular Events and Mortality
por: Linda R. Peterson, et al.
Publicado: (2018)

Incidence of cardiovascular events and mortality in Korean patients with chronic kidney disease
por: Hyunjin Ryu, et al.
Publicado: (2021)

Systolic Blood Pressure, Cardiovascular Mortality, and All-Cause Mortality in Normoglycemia, Prediabetes, and Diabetes
por: Chen CL, et al.
Publicado: (2020)

Obstructive sleep apnea and risk of cardiovascular events and all-cause mortality: a decade-long historical cohort study.
por: Tetyana Kendzerska, et al.
Publicado: (2014)

Impacts of Pre-Diabetes or Prehypertension on Subsequent Occurrence of Cardiovascular and All-Cause Mortality among Population without Cardiovascular Diseases
por: Huang Y, et al.
Publicado: (2020)

Better Medications Adherence Lowers Cardiovascular Events, Stroke, and All-Cause Mortality Risk: A Dose-Response Meta-Analysis
por: Mengying Liu, et al.
Publicado: (2021)

Influence of Statin Therapy on the Incidence of Cardiovascular Events, Cancer, and All-Cause Mortality in People Living With HIV: A Meta-Analysis
por: Yanping Li, et al.
Publicado: (2021)

Author Correction: Incidence of cardiovascular events and mortality in Korean patients with chronic kidney disease
por: Hyunjin Ryu, et al.
Publicado: (2021)

Oral health and all-cause, cardiovascular disease, and respiratory mortality in older people in the UK and USA
por: Eftychia Kotronia, et al.
Publicado: (2021)

The Associations of Two Novel Inflammation Indexes, SII and SIRI with the Risks for Cardiovascular Diseases and All-Cause Mortality: A Ten-Year Follow-Up Study in 85,154 Individuals
por: Jin Z, et al.
Publicado: (2021)

Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes.
por: Claudia Menzaghi, et al.
Publicado: (2014)

Serum urate and cardiovascular events in the DCCT/EDIC study
por: Alicia J. Jenkins, et al.
Publicado: (2021)

Pregnancy-associated plasma protein A as a predictor of all-cause mortality and cardiovascular events in patients with chronic kidney disease: a meta-analysis of prospective studies
por: Yuehua Li, et al.
Publicado: (2019)

No association between loss-of-function mutations in filaggrin and diabetes, cardiovascular disease, and all-cause mortality.
por: Lise Lotte N Husemoen, et al.
Publicado: (2013)

Association of handgrip strength with hospitalization, cardiovascular events, and mortality in Japanese patients with type 2 diabetes
por: Hidetaka Hamasaki, et al.
Publicado: (2017)

The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
por: Zhu Q, et al.
Publicado: (2016)

The Correlation Between Low Serum T3 Levels and All-Cause and Cardiovascular Mortality in Peritoneal Dialysis Patients
por: Xu LC, et al.
Publicado: (2021)

Renal markers and risks of all cause and cardiovascular mortality from the Taichung community based cohort study
por: Cheng-Chieh Lin, et al.
Publicado: (2021)

Sagittal abdominal diameter is an independent predictor of all-cause and cardiovascular mortality in incident peritoneal dialysis patients.
por: Mi Jung Lee, et al.
Publicado: (2013)

Onset of mortality increase with age and age trajectories of mortality from all diseases in the four Nordic countries
por: Dolejs J, et al.
Publicado: (2017)

Inflammation and cardiovascular diseases
por: Hui Wang, et al.
Publicado: (2020)

Sarcopenia modifies the associations of nonalcoholic fatty liver disease with all-cause and cardiovascular mortality among older adults
por: Xingxing Sun, et al.
Publicado: (2021)

Intronic Variants in OCT1 are Associated with All-Cause and Cardiovascular Mortality in Metformin Users with Type 2 Diabetes
por: Schweighofer N, et al.
Publicado: (2020)

Homocysteine and the Risk of Cardiovascular Events and All-Cause Death in Elderly Population: A Community-Based Prospective Cohort Study
por: Zhang Z, et al.
Publicado: (2020)

Mortality and cardiovascular events in adults with kidney failure after major non-cardiac surgery: a population-based cohort study
por: Tyrone G. Harrison, et al.
Publicado: (2021)

Sedentary time and markers of chronic low-grade inflammation in a high risk population.
por: Joseph Henson, et al.
Publicado: (2013)

Relationship between serum uric acid, all-cause mortality and cardiovascular mortality in peritoneal dialysis patients: systematic review and meta-analysis of cohort studies
por: Qiang Liu, et al.
Publicado: (2021)

Association of BMI, comorbidities and all-cause mortality by using a baseline mortality risk model.
por: Jia Li, et al.
Publicado: (2021)

Association of versican turnover with all-cause mortality in patients on haemodialysis.
por: Federica Genovese, et al.
Publicado: (2014)

Proteins as Mediators of the Association Between Diet Quality and Incident Cardiovascular Disease and All‐Cause Mortality: The Framingham Heart Study
por: Youjin Kim, et al.
Publicado: (2021)

Alcohol and Mortality from All Causes
por: RENAUD,SERGE, et al.
Publicado: (2004)

Inflammation and Cardiovascular Disease: The Future
por: Natalie Arnold, et al.
Publicado: (2021)

A Score of Low-Grade Inflammation for Predicting Stroke Recurrence in Patients with Ischemic Stroke
por: Wu M, et al.
Publicado: (2021)

The pattern-recognition molecule H-ficolin in relation to diabetic kidney disease, mortality, and cardiovascular events in type 1 diabetes
por: Jakob Appel Østergaard, et al.
Publicado: (2021)

Metabolically healthy obesity and the risk of all-cause and cardiovascular disease mortality in a Korean population: a prospective cohort study
por: Jong-Koo Lee, et al.
Publicado: (2021)

Cardiovascular Morbidity and Mortality in Adult Patients With Repaired Aortic Coarctation
por: Timion A. Meijs, et al.
Publicado: (2021)

Tendon healing is adversely affected by low-grade inflammation
por: Emanuele Chisari, et al.
Publicado: (2021)

Comparing the prognostic accuracy for all-cause mortality of frailty instruments: a multicentre 1-year follow-up in hospitalized older patients.
por: Alberto Pilotto, et al.
Publicado: (2012)

TP53 Arg72Pro, mortality after cancer, and all-cause mortality in 105,200 individuals
por: Jakob B. Kodal, et al.
Publicado: (2017)

The Involvement of Selenium in Type 2 Diabetes Development Related to Obesity and Low Grade Inflammation
por: Wongdokmai R, et al.
Publicado: (2021)